Skip to main content

Healthy

2198
Pipeline Programs
30
Companies
50
Clinical Trials
9 recruiting
17
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2057
14
28
5
20
74
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
29075%
Peptide
4111%
Monoclonal Antibody
4010%
Vaccine
164%
RNA Therapeutic
10%
+ 3691 programs with unclassified modality

On Market (17)

Approved therapies currently available

Johnson & Johnson
XARELTOApproved
Johnson & Johnson
oral2011
6.3B Part D
Johnson & Johnson
INVOKANAApproved
canagliflozin
Johnson & Johnson
oral2013
357M Part D
AbbVie
BOTOXApproved
onabotulinumtoxina
AbbVie
Acetylcholine Release Inhibitor [EPC]single-use1991
112M Part D
Otsuka
JYNARQUEApproved
tolvaptan
Otsuka
Vasopressin V2 Receptor Antagonist [EPC]oral2018
76M Part D
Johnson & Johnson
INVOKAMETApproved
canagliflozin and metformin hydrochloride
Johnson & Johnson
oral2014
22M Part D
Pfizer
NEURONTINApproved
gabapentin
Pfizer
oral2002
20M Part D
Otsuka
SAMSCAApproved
tolvaptan
Otsuka
Vasopressin V2 Receptor Antagonist [EPC]oral2009
12M Part D
GSK
SELZENTRYApproved
maraviroc
GSK
CCR5 Co-receptor Antagonist [EPC]oral2016
9M Part D
Otsuka
TOLVAPTANApproved
tolvaptan
Otsuka
oral2025
3M Part D
Pfizer
VFENDApproved
voriconazole
Pfizer
Azole Antifungal [EPC]intravenous2002
10K Part D
Pfizer
VORICONAZOLEApproved
voriconazole
Pfizer
Azole Antifungal [EPC]oral2016
AbbVie
BOTOX COSMETICApproved
onabotulinumtoxina
AbbVie
Acetylcholine Release Inhibitor [EPC]single-use1991
Baxter International
MYXREDLINApproved
insulin human
Baxter International
Insulin [EPC]intravenous2019
Johnson & Johnson
DURAGESIC-50Approved
Johnson & Johnson
transdermal1990
Novartis
OMNIPREDApproved
prednisolone acetate
Novartis
ophthalmic1973
Baxter International
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERApproved
cefazolin sodium
Baxter International
injection
Eli Lilly and Company
INLURIYOApproved
imlunestrant
Eli Lilly and Company
Estrogen Receptor Antagonist [EPC]oral2025

Competitive Landscape

428 companies ranked by most advanced pipeline stage

Pfizer
366 programs
339
1
2
7
10
Alivium®Phase 42 trials
Cymbalta CapsulesPhase 41 trial
Cymbalta capsulePhase 41 trial
MaravirocPhase 41 trial
PregabalinPhase 41 trial
+361 more programs
Active Trials
NCT01509105Completed649Est. Jan 2016
NCT00508950Completed152Est. Jun 2016
NCT00913406Completed232Est. May 2006
+418 more trials
AstraZeneca
172 programs
165
2
EsomeprazolePhase 4Small Molecule1 trial
NexiumPhase 41 trial
14C-AZD1236Phase 11 trial
ACH-0145228Phase 11 trial
ACH-0145228: Immediate ReleasePhase 11 trial
+167 more programs
Active Trials
NCT01031758Completed18Est. Jun 2010
NCT00860821Completed20Est. Oct 2009
NCT01308372Completed9,246Est. Oct 2011
+175 more trials
Sharp Therapeutics
106 programs
99
1
3
1
ertapenemPhase 4
Comparator: Varicella Zoster Virus VaccinePhase 3Vaccine
V110, pneumococcal vaccine polyvalentPhase 3Vaccine
V181Phase 3
V540A-2Phase 2
+101 more programs
MSD
106 programs
99
1
3
1
ertapenemPhase 4
Comparator: Varicella Zoster Virus VaccinePhase 3Vaccine
V110, pneumococcal vaccine polyvalentPhase 3Vaccine
V181Phase 3
V540A-2Phase 2
+101 more programs
Eli Lilly and Company
1
CelecoxibN/ASmall Molecule1 trial
Harvard Apparatus syringe pumpN/A1 trial
PropranololN/ASmall Molecule1 trial
5 mg empagliflozin/850 mg metformin FDCPHASE_11 trial
AbemaciclibPHASE_1Small Molecule1 trial
+55 more programs
Active Trials
NCT02413203Completed20Est. Nov 2015
NCT06516913Completed32Est. Sep 2024
NCT04682184Completed21Est. Mar 2021
+73 more trials
Sandoz
60 programs
47
1
1
4
DarifenacinPhase 41 trial
Povidone K25 eye dropsPhase 41 trial
Prednisolone acetatePhase 41 trial
olanzapinePhase 41 trial
rMenBPhase 21 trial
+55 more programs
Active Trials
NCT02480049Completed26Est. Aug 2014
NCT02479854Completed24Est. Apr 2014
NCT00882570Completed40Est. May 2005
+55 more trials
Human BioSciences
8
2
5
1
2
MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]Phase 41 trial
Testosterone EnanthatePhase 41 trial
Testosterone gelPhase 2/31 trial
AcylinePhase 21 trial
Dimethandrolone-UndecanoatePhase 2
+53 more programs
Active Trials
NCT01007188Completed18Est. May 2010
NCT01802151Completed83Est. Oct 2012
NCT02612597Unknown20Est. Apr 2016
+48 more trials
Lundbeck
38 programs
33
3
EscitalopramPhase 41 trial
Escitalopram 20 mgPhase 41 trial
escitalopram and tramadolPhase 41 trial
Cohort A1: Lu AE58054 or placeboPhase 11 trial
Drug CocktailPhase 11 trial
+33 more programs
Active Trials
NCT00150527Completed8Est. Dec 2007
NCT00612079Completed30Est. Nov 2008
NCT01975779Completed42
+34 more trials
Biocorp
33 programs
17
3
3
2
1
bOPVPhase 41 trial
DTP/HB/Hib VaccinePhase 3Vaccine1 trial
Ulmus macrocarpa water extractPhase 31 trial
HRIGPhase 2/31 trial
PentavalenPhase 2/31 trial
+28 more programs
Active Trials
NCT05749068Completed10Est. Oct 2022
NCT05939336Active Not Recruiting40Est. Jun 2026
NCT07128966Recruiting100,000Est. Sep 2036
+28 more trials
Johnson & Johnson
1
Brush OnlyN/A1 trial
Characterization of the Edge of Soft Contact Lens and Its Interaction With Ocular SurfaceN/A1 trial
Evaluation of Cow Milk-Based Formulas - Functional ProteinsN/A1 trial
Sunscreen C Color 2.0 SPF 70N/A1 trial
Sunscreen Color tone 2.0N/A1 trial
+21 more programs
Active Trials
NCT06798441Completed161Est. Feb 2025
NCT00707291Completed61Est. Jun 2011
NCT00916565Completed139
+32 more trials
ViiV Healthcare
26 programs
13
1
1
2
MaravirocPhase 4
Meningococcal BPhase 41 trial
MaravirocPhase 21 trial
MEDI 517Phase 1/21 trial
CefadroxilPhase 11 trial
+21 more programs
Active Trials
NCT01771354Completed24Est. Aug 2014
NCT02284074Completed15Est. Apr 2011
NCT00388765Completed10Est. Nov 2006
+15 more trials
GSK
23 programs
1
Nasal LPS sprayN/A
Normal Control Cohort Sample BankN/A
Pilot Study to Assess Feasibility, Reliability and Validity of the e-SSRS-IVRN/A
RaltegravirN/ASmall Molecule
RaltegravirN/ASmall Molecule
+18 more programs
Active Trials
NCT06179537Completed34Est. Nov 2021
NCT05244759Completed6Est. Mar 2021
Novartis
NovartisBASEL, Switzerland
21 programs
1
AEB071PHASE_1
AEB071PHASE_1
AHT956PHASE_1
AQW051PHASE_1
AQW051PHASE_1
+16 more programs
Abbott
AbbottABBOTT PARK, IL
20 programs
7
1
1
4
cefdinirPhase 41 trial
cefdinirPhase 41 trial
cefdinirPhase 41 trial
divalproex sodiumPhase 41 trial
Milk based formula APhase 2/31 trial
+15 more programs
Active Trials
NCT00718042Completed41,862Est. Sep 2009
NCT04862065Completed16,388Est. Aug 2021
NCT03285295Completed106,881Est. Jun 2018
+17 more trials
Baxter International
19 programs
5
1
recombinant human hyaluronidasePhase 4
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER(Cefazolin)Phase 1
CordaronePhase 1
MYXREDLIN(Insulin)Phase 1
PM10Phase 1
+14 more programs
Active Trials
NCT03884582Completed14Est. May 2019
NCT07158333Completed15Est. Sep 2025
NCT01457183Withdrawn0Est. Oct 2012
+4 more trials
Colorado Therapeutics
1
1
SitagliptinPhase 4Small Molecule1 trial
LowTPhase 21 trial
Adenine 5+N/A
CannabidiolN/A1 trial
Cannabidiol CapsulesN/A1 trial
+13 more programs
Active Trials
NCT04881539Completed50Est. Mar 2022
NCT06364254Unknown30Est. May 2024
NCT06254898Completed186Est. Jun 2026
+13 more trials
JW Pharmaceutical
17
1
Combiflex® lipid periPhase 41 trial
Epaminurad 9 mgPhase 11 trial
Epaminurad, NaproxenPhase 11 trial
Group 1: JW0104Phase 11 trial
JW2286Phase 11 trial
+13 more programs
Active Trials
NCT07374406Completed34Est. Feb 2026
NCT06435442Completed57Est. Dec 2025
NCT06378684Completed48Est. Jan 2024
+15 more trials
Medica Corp
16 programs
3
1
4
PentoxifyllinePhase 41 trial
Revolade®Phase 41 trial
Rivotril®Phase 41 trial
Theralite®Phase 41 trial
DLBS1033Phase 2
+11 more programs
Active Trials
NCT06823362Not Yet Recruiting40Est. Sep 2025
NCT06834451Active Not Recruiting30Est. Oct 2025
NCT06834503Not Yet Recruiting24Est. Nov 2025
+1 more trials
AbbVie
13 programs
12
1
onabotulinumtoxinAPhase 41 trial
ABBV-CLS-7262Phase 11 trial
ABBV-CLS-7262Phase 11 trial
ABBV-CLS-7262Phase 11 trial
BIIB019 subcutaneous injectionPhase 11 trial
+8 more programs
Active Trials
NCT05763459Completed12Est. Jun 2023
NCT06145607Completed18Est. Feb 2024
NCT06310876Completed72Est. Jun 2024
+10 more trials
Otsuka
13 programs
10
3
CilostazolPhase 41 trial
TolvaptanPhase 41 trial
probucolPhase 41 trial
ACU-4429Phase 1
BrexpiprazolePhase 1Small Molecule1 trial
+8 more programs
Active Trials
NCT03734302Completed10Est. Jun 2020
NCT06143371Completed80Est. Nov 2025
NCT02554721Completed77Est. Mar 2018
+9 more trials
Bayer
12 programs
7
1
2
Climodien / LafammePhase 41 trial
YasminPhase 41 trial
YasminPhase 31 trial
DexpanthenolPhase 11 trial
MoxifloxacinPhase 1Small Molecule1 trial
+7 more programs
Active Trials
NCT00313118Withdrawn0Est. Dec 2016
NCT03003442Completed91Est. Oct 2017
NCT00885937Completed33Est. May 2009
+4 more trials
Medtronic
10 programs
1
1
3
Evaluation of propofol effectPhase 41 trial
Radical 7Phase 41 trial
Radical-7Phase 41 trial
Arterial linePhase 31 trial
Cleaning capsulePhase 11 trial
+5 more programs
Active Trials
NCT02506010Withdrawn0Est. Jan 2017
NCT02216344Completed13Est. Sep 2014
NCT00949208Completed1,225Est. Aug 2016
+7 more trials
Solventum
7 programs
4
2
AvagardPhase 41 trial
ChloraPrepPhase 41 trial
TiotropiumPhase 11 trial
TiotropiumPhase 11 trial
tiotropiumPhase 11 trial
+2 more programs
Active Trials
NCT04869696Completed56Est. May 2021
NCT02627625Completed31Est. Jun 2016
NCT03302065Completed38Est. Jan 2017
+4 more trials
Halozyme Therapeutics
5
2
HylenexPhase 41 trial
recombinant human hyaluronidasePhase 41 trial
Cohort 1: bococizumab 150 mg + rHuPH20Phase 11 trial
HylenexPhase 11 trial
OndansetronPhase 11 trial
+2 more programs
Active Trials
NCT02667223Terminated60Est. Jul 2016
NCT00435604Completed15Est. May 2007
NCT01572012Completed12Est. Nov 2013
+4 more trials
Enterprise Therapeutics
1
1
SertralinePhase 41 trial
ETD002 - single dosePhase 11 trial
rice protein RP-80NN/A1 trial
Active Trials
NCT05560048Unknown18Est. Jan 2023
NCT04488705Completed80Est. May 2021
NCT00969852Completed10Est. Mar 2010
Sound Pharmaceuticals
1
Suction-assisted LipoplastyPhase 41 trial
weighted waist-hoopingN/A1 trial
Active Trials
NCT04213560Completed27Est. Dec 2018
NCT00731354Completed21Est. Apr 2009
Amgen
AmgenTHOUSAND OAKS, CA
2 programs
1
1
leptinPhase 42 trials
HPN-100Phase 11 trial
Active Trials
NCT00977600Completed24Est. Jul 2005
NCT00121433Completed15Est. Dec 2004
NCT01207934Completed18Est. Jul 2000
Dr. Falk Pharma
2 programs
1
1
Budesonide 2 single doses, Metronidazole multiple-dosePhase 41 trial
UDCAPhase 11 trial
Active Trials
NCT00529009Completed
NCT00338910Completed12Est. Jun 2006
MCM Vaccines
1 program
1
Meningococcal BPhase 4
Currax Pharmaceuticals
1
Silenor 6 mgPhase 41 trial
Active Trials
NCT02353299Completed52Est. Mar 2016

+398 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Merck & Co.Sotatercept
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Merck & Co.Sotatercept
Johnson & JohnsonA
Medica CorpRivotril®
Johnson & JohnsonA
Medica CorpRevolade®
Johnson & JohnsonA
Merck & Co.Sotatercept

Showing 15 of 49 trials with date data

Clinical Trials (50)

Total enrollment: 5,697 patients across 50 trials

A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder

Est. completion: Aug 200359 patients
Phase 4Completed

A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.

Est. completion: Oct 2004650 patients
Phase 4Completed

The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)

Phase 4Unknown

A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

Start: Oct 2026Est. completion: Aug 202710 patients
Phase 4Not Yet Recruiting

The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression

Start: Jul 2026Est. completion: Jul 202825 patients
Phase 4Not Yet Recruiting

A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

Start: Jul 2026Est. completion: Apr 202830 patients
Phase 4Not Yet Recruiting

Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients

Start: May 2026Est. completion: May 2028401 patients
Phase 4Not Yet Recruiting

A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)

Start: Dec 2025Est. completion: Nov 202778 patients
Phase 4Recruiting

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

Start: Oct 2025Est. completion: Oct 2027115 patients
Phase 4Recruiting

Sotatercept in Pulmonary Arterial Hypertension

Start: Oct 2025Est. completion: Jan 203027 patients
Phase 4Recruiting

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Start: Aug 2025Est. completion: Sep 2027100 patients
Phase 4Recruiting

Bioequivalence Study of Clonazepam 2 Mg Tablets

Start: Jun 2025Est. completion: Nov 202524 patients
Phase 4Not Yet Recruiting

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Start: Jun 2025Est. completion: Jul 202647 patients
Phase 4Completed

Bioequivalence Study of Revolade® Eltrombopag 50 mg

Start: Jun 2025Est. completion: Oct 202530 patients
Phase 4Active Not Recruiting

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

Start: May 2025Est. completion: Jun 202775 patients
Phase 4Active Not Recruiting

Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)

Start: May 2025Est. completion: May 202620 patients
Phase 4Recruiting

Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions

Start: Apr 2025Est. completion: Sep 202540 patients
Phase 4Not Yet Recruiting

Plan Development for Giving Teclistamab in the Outpatient Setting

Start: Nov 2024Est. completion: Oct 202615 patients
Phase 4Recruiting

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Start: Sep 2024Est. completion: Sep 2026734 patients
Phase 4Recruiting

Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects

Start: Jun 2024Est. completion: Apr 202524 patients
Phase 4Active Not Recruiting
NCT06136455Johnson & JohnsonListerine Clinical Solutions Teeth Strength

A Study to Investigate Salivary Flow and Potential of Hydrogen (pH) Following Use of Essential-Oil Containing Mouthwashes

Start: Nov 2023Est. completion: Nov 2023164 patients
Phase 4Completed

Positioning of Esketamine Treatment in the Real-world Management of Depression

Start: Oct 2023Est. completion: Jan 2026162 patients
Phase 4Unknown
NCT06010758Johnson & JohnsonListerine Experimental Mouthwash

A Two-Week Study of an Anticavity Low pH Mouthwash

Start: Jul 2023Est. completion: Aug 2023163 patients
Phase 4Completed

Immune Spatial Features of Guselkumab Cutaneous Response

Start: Jul 2023Est. completion: Jun 202810 patients
Phase 4Recruiting

Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain

Start: Mar 2023Est. completion: Mar 202530 patients
Phase 4Unknown
NCT05756673Johnson & JohnsonColgate Cavity Protection Toothpaste

A Study of Virtually Supervised Mouthwash and Interdental Brushes

Start: Feb 2023Est. completion: Oct 2023292 patients
Phase 4Completed

Home Based Daratumumab Administration for Patients With Multiple Myeloma

Start: Nov 2022Est. completion: May 202420 patients
Phase 4Completed
NCT05526586Johnson & JohnsonColgate Cavity Protection Toothpaste

A Twelve Week Study of Prototypes Mouth Rinses

Start: Aug 2022Est. completion: Dec 2022192 patients
Phase 4Completed

Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

Start: May 2022Est. completion: Feb 202319 patients
Phase 4Completed
NCT05600231Johnson & JohnsonLISTERINE COOL MINT Antiseptic Mouthwash

A Study of Virtually Supervised Mouth Rinses and Flossing

Start: Apr 2022Est. completion: Jul 2022284 patients
Phase 4Completed

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Start: Mar 2022Est. completion: Jun 2042295 patients
Phase 4Recruiting

A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Start: Dec 2021Est. completion: May 2025182 patients
Phase 4Completed

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

Start: Nov 2021Est. completion: Jul 202315 patients
Phase 4Terminated

A Study of Experimental Mouthwashes

Start: Nov 2021Est. completion: Apr 2022274 patients
Phase 4Completed

Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

Start: Sep 2021Est. completion: Apr 202475 patients
Phase 4Completed

Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants

Start: Aug 2021Est. completion: Apr 202277 patients
Phase 4Completed

A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

Start: Jul 2021Est. completion: Apr 202493 patients
Phase 4Completed

A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Start: Jul 2021Est. completion: Oct 202353 patients
Phase 4Completed

A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

Start: Apr 2021Est. completion: Jul 2024183 patients
Phase 4Completed

Guselkumab Immunogenetics

Start: Mar 2021Est. completion: Apr 202517 patients
Phase 4Completed

Inflammation and Co-Infections in D²EFT

Start: Feb 2021Est. completion: Dec 20220
Phase 4Withdrawn

A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Start: Nov 2020Est. completion: Jul 2022276 patients
Phase 4Completed

Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan

Start: Nov 2020Est. completion: Mar 2025100 patients
Phase 4Unknown

A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

Start: Jul 2020Est. completion: Aug 2023103 patients
Phase 4Completed
NCT04239339LundbeckEscitalopram 20 mg

Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy Volunteers

Start: Apr 2020Est. completion: Oct 202266 patients
Phase 4Completed
NCT03794154PfizerCymbalta capsule

A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions

Start: Mar 2020Est. completion: Jun 20200
Phase 4Withdrawn
NCT03729284PfizerCymbalta Capsules

A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta

Start: Mar 2020Est. completion: Jun 20200
Phase 4Withdrawn

Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy

Start: Jan 2020Est. completion: Aug 202130 patients
Phase 4Unknown

A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)

Start: Dec 2019Est. completion: Mar 202417 patients
Phase 4Completed

Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)

Start: Sep 2019Est. completion: Dec 20211 patients
Phase 4Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

20 late-stage (Phase 3) programs, potential near-term approvals
9 actively recruiting trials targeting 5,697 patients
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.